Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.

Proc Natl Acad Sci U S A

BioTherapeutics Research Group, Robarts Research Institute and Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada N6G 2V4.

Published: March 2006

AI Article Synopsis

  • The susceptibility of human cancer cells to oncolytic myxoma virus (MV) infection is linked to the levels of phosphorylated Akt in those cells.
  • Nonpermissive tumor cells can become susceptible to MV by expressing active Akt, while permissive cells can become resistant by inhibiting Akt activation.
  • The interaction between MV's M-T5 protein and Akt is crucial for this activation, highlighting the Akt pathway as a significant factor in determining how susceptible human cancer cells are to MV.

Article Abstract

We demonstrate that the susceptibility of human cancer cells to be infected and killed by an oncolytic poxvirus, myxoma virus (MV), is related to the basal level of endogenous phosphorylated Akt. We further demonstrate that nonpermissive tumor cells will switch from resistant to susceptible for MV infection after expression of ectopically active Akt (Myr-Akt) and that permissive cancer cells can be rendered nonpermissive by blocking Akt activation with a dominant-negative inhibitor of Akt. Finally, the activation of Akt by MV involves the formation of a complex between the viral host range ankyrin-repeat protein, M-T5, and Akt. We conclude that the Akt pathway is a key restriction determinant for permissiveness of human cancer cells by MV.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1450224PMC
http://dx.doi.org/10.1073/pnas.0509341103DOI Listing

Publication Analysis

Top Keywords

cancer cells
16
human cancer
12
myxoma virus
8
akt
8
akt activation
8
host range
8
cells
5
infection human
4
cancer
4
cells myxoma
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!